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ABSTRACT Fluoridation of drinking water and dental products prevents dental car-
ies primarily by inhibiting energy harvest in oral cariogenic bacteria (such as Strepto-
coccus mutans and Streptococcus sanguinis), thus leading to their depletion. How-
ever, the extent to which oral and gut microbial communities are affected by host
ﬂuoride exposure has been underexplored. In this study, we modeled human ﬂuo-
ride exposures to municipal water and dental products by treating mice with low or
high levels of ﬂuoride over a 12-week period. We then used 16S rRNA gene ampli-
con and shotgun metagenomic sequencing to assess ﬂuoride’s effects on oral and
gut microbiome composition and function. In both the low- and high-ﬂuoride
groups, several operational taxonomic units (OTUs) belonging to acidogenic bacte-
rial genera (such as Parabacteroides, Bacteroides, and Bilophila) were depleted in the
oral community. In addition, ﬂuoride-associated changes in oral community compo-
sition resulted in depletion of gene families involved in central carbon metabolism
and energy harvest (2-oxoglutarate ferredoxin oxidoreductase, succinate dehydroge-
nase, and the glyoxylate cycle). In contrast, ﬂuoride treatment did not induce a sig-
niﬁcant shift in gut microbial community composition or function in our mouse
model, possibly due to absorption in the upper gastrointestinal tract. Fluoride-
associated perturbations thus appeared to have a selective effect on the composi-
tion of the oral but not gut microbial community in mice. Future studies will be
necessary to understand possible implications of ﬂuoride exposure for the human
microbiome.
IMPORTANCE Fluoride has been added to drinking water and dental products since
the 1950s. The beneﬁcial effects of ﬂuoride on oral health are due to its ability to in-
hibit the growth of bacteria that cause dental caries. Despite widespread human
consumption of ﬂuoride, there have been only two studies of humans that consid-
ered the effect of ﬂuoride on human-associated microbial communities, which are
increasingly understood to play important roles in health and disease. Notably, nei-
ther of these studies included a true cross-sectional control lacking ﬂuoride expo-
sure, as study subjects continued baseline ﬂuoride treatment in their daily dental hy-
giene routines. To our knowledge, this work (in mice) is the ﬁrst controlled study to
assess the independent effects of ﬂuoride exposure on the oral and gut microbial
communities. Investigating how ﬂuoride interacts with host-associated microbial
communities in this controlled setting represents an effort toward understanding
how common environmental exposures may potentially inﬂuence health.
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Fluoride depletes acidogenic taxa in oral
communities in mice. Gut microbiome was
unaffected possibly due to absorption in the
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Since the 1940s, ﬂuoridation of drinking water and dental products has beenemployed as a public health measure to prevent dental caries. In the United States,
more than 60% of municipal water is ﬂuoridated, and the majority of dental products
contain ﬂuoride (1–3). Fluoridated compounds improve oral health by inhibiting bac-
terial growth through inhibition of the enzyme enolase, which catalyzes the conversion
of 2-phosphoglycerate to phosphoenolpyruvate (the last step of anaerobic glycolysis)
and thus is critical for microbial energy harvest and growth (4, 5). Inhibition of
individual oral bacteria such as Streptococcus mutans by ﬂuoride has been well studied
(6–8), but how ﬂuoride affects the overall oral microbiome or the gut microbiome has
been underinvestigated.
The major mechanisms by which ﬂuoride inhibits bacterial energy growth are direct
binding of the ﬂuorine ion to the active sites of enolase (5) and ATPases (9) and
disruption of the ion gradient across the bacterial cell membrane (10, 11). All of these
mechanisms result in the reduction of ATP synthesis (9). Although a wide range of
bacterial taxa are inhibited by this mechanism, the degree of resistance differs across
taxa. For example, the enolases of Streptococcus mutans and Streptococcus sanguis are
more susceptible (by 10-fold) to ﬂuoride than those of Streptococcus salivarius and
Lactobacillus casei in monoculture (9, 12). This variation in ﬂuoride resistance raises the
question of how ﬂuoride affects individual bacterial taxa within a complex microbial
community. Two recent studies have begun extending this line of investigation to
dental plaque microbial communities using high-throughput sequencing (13, 14).
Unfortunately, neither of these studies included a true control group to properly assess
ﬂuoride’s effects on the oral microbiome (individuals in the studies’ control groups
retained access to commercial ﬂuoride-containing dental products and ﬂuoride in
drinking water during the experimental period). Moreover, one of these studies con-
sidered a single dose of sodium ﬂuoride mouthwash (13) and was therefore not
designed to assess the effects of longer-term exposures. Thus, no existing study has
tested the effects of ﬂuoride exposures at the levels found in municipal water and
dental products on the oral and gut microbial communities.
We address these questions by assessing oral and stool microbiome structures and
their functional potentials in mice given (i) nonﬂuoridated drinking water, (ii) ﬂuori-
dated drinking water, or (iii) daily ﬂuoride gavage in addition to ﬂuoridated drinking
water over 12 weeks. 16S rRNA gene amplicon and shotgun metagenomic sequencing
revealed that ﬂuoride exposure signiﬁcantly perturbed oral but not gut microbiome
composition in mice. Speciﬁcally, ﬂuoride selectively depleted oral acidogenic bacteria,
including Bacteroides, Parabacteroides, and Bilophila. In terms of the microbial func-
tional proﬁles, ﬂuoride exposure selectively depleted metabolic modules important for
central carbon metabolism. Our results support the idea that ﬂuoride-associated per-
turbations have a selective effect on the composition of the oral microbial community
in mice. Though limited by lack of human data, this study suggests that the levels of
ﬂuoride currently added to drinking water and associated with routine use of dental
products are unlikely to have signiﬁcant effects on established gut microbial commu-
nities.
RESULTS
Drivers of oral and gut microbial diversity in ﬂuoride-treated mice. To elucidate
the effects of chronic ﬂuoride exposure on oral and gut microbial communities,
wild-type BALB/c mice (1 month of age) were randomized upon weaning to the
following experimental groups: (i) unﬂuoridated (deionized) drinking water, (ii) ﬂuori-
dated drinking water (4 ppm), or (iii) ﬂuoridated drinking water (4 ppm) plus a daily
gavage of ﬂuoride similar to a dose ingested when swallowing dental ﬂuoride products
(2.25 g of ﬂuoride per day via gavage) for a period of 12 weeks. Oral samples were
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collected at 0 and 12 weeks, and stool samples were collected at 0, 4, 8, and 12 weeks.
Since the collection of oral samples required animals to be sacriﬁced, eight mice were
taken for oral week 0 sample at random when the rest of the animals were allocated
to the study groups. To measure the effects of ﬂuoride on the composition of the
microbial community, we used amplicon sequencing of the 16S ribosomal rRNA gene,
speciﬁcally hypervariable region V4 (referred to hereafter as 16S) (see Materials and
Methods).
We ﬁrst examined the major factors driving microbial diversity across our data set by
applying permutational multivariate analysis of variance (PERMANOVA) (adonis R pack-
age) to weighted UniFrac distance. Biogeographical site (oral versus gut) explained the
largest fraction of between-sample diversity (45%, P  0.001; Fig. 1A). This observation
is consistent with the strong effect of biogeography on microbial community structure
seen in other mammals (15, 16). Downstream nonparametric comparison of oral and
gut samples (17) revealed statistically signiﬁcant enrichments of Streptococcus spp. and
Pasteurellaceae species in the oral site, while the gut was enriched for Bacteroides,
Clostridiales, Lachnospiraceae, and Parabacteroides (Fig. 1E and see Table S1 in the
supplemental material). Notably, these clades are similarly enriched in human oral and
gut sites, respectively (15, 18, 19).
Housing cage (Fig. S1A) and treatment time point (Fig. 1B and Fig. S1B) explained
additional, signiﬁcant fractions of between-sample diversity (29% and 4%, respectively).
Speciﬁcally, within-cage stool communities (Fig. S1A and E) were signiﬁcantly more
similar than between-cage communities (P  0.001 by Mann-Whitney U test on
weighted UniFrac distance), as observed in previous studies (20). These cage effects
corresponded to recognizable sample subgroups dominated by either (i) Clostridiales
and Lachnospiraceae or (ii) Bacteroides and Parabacteroides. Curiously, we did not ﬁnd
oral samples to be signiﬁcantly more similar within cages than between cages (P 
FIG 1 Drivers of oral and gut microbial diversity in ﬂuoride-treated mice. (A) Principal-coordinate analysis (PCoA) of all samples by weighted UniFrac distance.
PCO1, principal coordinate 1. (B) PCoA of stool samples by weighted UniFrac distance. (C) PCoA of oral samples at week 12 by weighted UniFrac distance. (D)
PCoA of stool samples at week 12 by weighted UniFrac distance. (E) Genus-level relative abundance of the oral and stool microbiota. Individual columns
represent individual animals and are grouped by treatment (control, low, and high ﬂuoride).
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0.34), suggesting that cage effects may be less pronounced among the mouse oral
microbiota. On the basis of these observations, we explicitly controlled for cage effects
in downstream analyses of stool.
While overview ordination suggested a slight separation among week 12 oral
samples associated with ﬂuoride treatment (Fig. 1C), we did not observe a separation
in stool samples (Fig. 1D and Fig. S1D), and the component of between-sample
diversity explained by ﬂuoride was not statistically signiﬁcant by PERMANOVA (P 
0.860). This suggests that ﬂuoride treatment does not have a large effect on the global
structure of the oral or gut microbiota in mice. However, it remained possible that
ﬂuoride treatment could selectively alter the abundance of individual microbial taxa
and functions in these environments.
Fluoride selectively depletes oral acidogenic taxa in mice. To identify bacterial
taxa selectively affected by ﬂuoride in the oral site, we performed multivariate analyses
using MaAsLin (Multivariate Associations by Linear models) (21) with ﬂuoride exposure
coded as a categorical variable: high-ﬂuoride exposure versus low-ﬂuoride exposure
versus no exposure (control). We considered only the week 12 oral samples (n  21)
and isolated associations with false-discovery rate (FDR)-corrected q values of 0.2 as
statistically signiﬁcant. In both the low- and high-ﬂuoride groups, obligate anaerobes
such as Parabacteroides distasonis, Bacteroides uniformis, and an unclassiﬁed species of
Bacteroides were consistently depleted compared to the control group (Fig. 2A and
Table S2). Sutterella and Bilophila were also depleted in ﬂuoride-treated animals but
only signiﬁcantly so in the high-ﬂuoride group (Fig. 2B). Such a pattern is consistent
with previous in vitro studies of dosage-dependent inhibition of enolase in different
microbial oral isolates (22). Curiously, unclassiﬁed species of Bacteroidales and Burk-
holderia were signiﬁcantly depleted only in the low-ﬂuoride group compared to the
control group (Fig. 2C), possibly due to more extreme depletion of other taxa in the
high-ﬂuoride group. A similar mechanism would explain the expansion of another
obligate anaerobe (an unclassiﬁed Ruminobacter species) in the high-ﬂuoride group
relative to the control group (Fig. 2D).
We performed a similar multivariate analysis to identify ﬂuoride-sensitive taxa
among stool samples. Relative to the model described above, we also considered
treatment time point and animal cage as covariates (i.e., week 4, week 8, and week 12
FIG 2 Fluoride selectively depletes acidogenic anaerobes in the oral microbiota. (A to C) Multivariate linear model association results (21) showing bacterial
OTUs that are consistently depleted in low- and high-ﬂuoride treatment groups (A), affected only in the high-ﬂuoride group (B), or the low-ﬂuoride group
compared to the control group (C). (D) A bacterial OTU enriched in the high-ﬂuoride group.
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samples were all considered). However, no species- or genus-level taxa showed signif-
icant (FDR-corrected q value of0.2) associations with the high- or low-ﬂuoride groups
relative to the control group. Results were similar when applying the model separately
to samples stratiﬁed by treatment time point. While our inability to detect a signiﬁcant
treatment effect in stool could be a result of small sample size, an alternative expla-
nation is that orally administered ﬂuoride does not reach the gut in large enough
quantities to perturb the gut microbiota. Previous research has suggested that ﬂuoride
absorption occurs mainly in the stomach and upper small intestine (23). We conﬁrmed
this result by directly measuring ﬂuoride levels in the stools of treated mice versus
untreated mice. Even after 12 weeks of high-ﬂuoride treatment, ﬂuoride levels in the
stools of treated mice were not signiﬁcantly higher than baseline (control) stool ﬂuoride
levels (P  0.05 by one-tailed t test; see Materials and Methods and Fig. S2). Hence,
while the gut microbiota may be sensitive to ﬂuoride, orally administered ﬂuoride (even
at high doses) is unlikely to expose this sensitivity.
Fluoride perturbs predicted oral microbial community functional potential. In
addition to affecting individual microbial taxa, ﬂuoride exposure may alter community-
level function by enriching or depleting taxa that encode speciﬁc metabolic modules.
Notably, this could be true in the gut, even though individual taxa failed to show a
signiﬁcant effect there. To test this hypothesis in our data, we used PICRUSt (Phyloge-
netic Investigation of Communities by Reconstruction of Unobserved States) (24) to
infer community gene content from 16S amplicon sequencing data, followed by
HUMAnN (25) to reconstruct functional modules. We then applied the same multivar-
iate testing framework described above to identify modules whose relative abundance
varied with ﬂuoride treatment (focusing on modules with relative abundance of
0.001% in at least ﬁve samples).
No functional modules varied signiﬁcantly with ﬂuoride treatment in the gut after
adjusting for treatment time point and animal cage effects (all FDR-corrected q values
of0.2). However, in the oral samples, 19 of the 113 observed functional modules were
differentially abundant among the treatment groups (Table S3). Fluoride treatment was
associated with depletions in the glyoxylate cycle (Kyoto Encyclopedia of Genes and
Genomes [KEGG] module M00012), succinate dehydrogenase (KEGG module M00149),
and second-carbon oxidation (KEGG module M00311) reﬂecting perturbed central
carbon metabolism (Fig. S3A). In addition, depletion in the mevalonate (MVA) pathway
for isoprenoid biosynthesis (KEGG module M00095) was also associated with ﬂuoride
treatment. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase, a key enzyme in the
MVA pathway, has previously been shown to be ﬂuoride sensitive (26, 27). Carriage of
the MVA pathway is limited to Gram-positive taxa such as Streptococcus, Lactobacillus,
and Staphylococcus (28). Individually, these taxa were not found to be signiﬁcantly
depleted in ﬂuoride-treated communities via multivariate analysis (Table S2). This
analysis suggests that the changes reﬂected in differentially abundant oral functional
modules may result from cumulative small changes in microbial community composi-
tion rather than large changes in speciﬁc taxa.
The quality of the predicted functional proﬁles analyzed above can be estimated
from the nearest sequenced taxon index (NSTI), which measures the closeness of a
16S-based proﬁle to known reference genomes. NSTI values for our samples were low
(i.e., close to reference), and mean NSTI scores for oral and gut samples were 0.047 and
0.148, respectively (Table S4 and Fig. S3C). This range of NSTI values (i) is consistent with
other nonhuman mammal-associated samples and (ii) suggests that predicted versus
measured functional proﬁles for these samples should be in reasonably strong agree-
ment (see Fig. 3 in reference 24). This agreement was also directly measured by
subjecting a subset of samples to shotgun metagenomic sequencing and proﬁling
(described in a subsequent section).
Fluoride affects stool-derived microbes in the mouse oral microbial commu-
nity. We hypothesized above that the lack of ﬂuoride treatment effect in the gut could
be due to the low concentration of ﬂuoride reaching that environment. In principle, gut
Fluoride Effects on Oral Microbiome
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microbes exposed to ﬂuoride in the oral cavity (where concentrations are expected to
be higher during treatment) might reveal additional sensitivity. While oral and gut
microbial taxa are largely distinct in humans (15), mice are coprophagic, and hence
have much greater potential for cooccurrence of oral and gut microbes (thus providing
a basis to test this hypothesis).
We began by dividing mouse operational taxonomic units (OTUs) according to their
biogeographic occurrence patterns (Fig. 3A and Fig. S4). We focused on OTUs that were
conﬁdently detected among the week 12 oral or gut samples, deﬁned as having a
relative abundance of 104 (0.01%) in at least ﬁve samples from at least one body
site. OTUs that were conﬁdently detected in only a single site were classiﬁed as “mostly
oral” (n  21) and “mostly gut” (n  10). Thirty-two additional OTUs were conﬁ-
dently detected at both sites. We further divided these OTUs into groups based on their
likely point of origin. “Cooccurring, oral native” OTUs (n  3) were deﬁned to have
mean oral abundance of more than twofold higher than the mean gut abundance and
may cooccur as a result of oral-gut transit. Conversely, 27 OTUs were classiﬁed as
“cooccurring, gut native” due to more than twofold higher mean abundance in the gut
(the two remaining cooccurring OTUs were classiﬁed as having an “ambiguous” point
of origin). Hence, oral sites are colonized by a relatively large number of gut bacterial
taxa in mice, which is likely the result of direct or indirect ingestion of stool (with
indirect ingestion of stool including grooming of stool-contaminated body parts).
We next reexamined the behavior of the 27 orally occurring, stool-derived taxa upon
ﬂuoride treatment based on the modeling results described above. While none of these
taxa were signiﬁcantly perturbed in the analysis of stool data, six were differentially
abundant between week 12 control and low- or high-ﬂuoride treatment oral samples.
The most abundant of these taxa include Parabacteroides distasonis, Bacteroides uni-
formis, and unclassiﬁed species of Bacteroides (Fig. 3B). In fact, the taxa that were
depleted among ﬂuoride-treated oral samples were weakly enriched for taxa derived
from the stool (P  0.034 by two-tailed Fisher exact test). This suggests that species
FIG 3 Fluoride affects stool-derived taxa found in the oral cavity. (A) Sixty-three abundant OTUs (rows) across oral and stool samples (columns). Rows and
columns are clustered by Bray-Curtis dissimilarity. OTUs are shown in colors according to their biogeographic occurrence/cooccurrence patterns (see main text
for deﬁnitions). OTUs that were signiﬁcantly depleted in ﬂuoride-treated oral samples are shown in red, including a subset of orally abundant, stool-derived
OTUs. The six OTUs in this subset with the greatest treatment effects are highlighted in panel B. Horizontal lines represent individual relative abundance
measurements (colored by treatment group), and measurements from the same animal are connected.
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native to the mouse stool microbiota are indeed sensitive to ﬂuoride in concentrations
typical of ﬂuoridated water or dental products. However, these taxa are likely protected
from ﬂuoride exposure in stool due to the absorption of ﬂuoride in the stomach and
small intestine.
Targeted metagenomic sequencing supports 16S-based conclusions. In addi-
tion to the 16S-based sequencing proﬁles introduced above, we assayed subsets of oral
(n  6) and stool (n  11) samples by shotgun metagenomic sequencing and proﬁled
them with MetaPhlAn2 (29) (for microbial taxonomy) and HUMAnN2 (for gene families
and pathways). While the shotgun-sequenced subset was too small for independent,
well-powered statistical analysis, it proved useful for supporting our 16S-based ﬁndings
and for boosting taxonomic and functional resolution.
To facilitate shotgun 16S comparisons, all taxonomic features were collapsed to the
family level. Of the 32 microbial families detected by reference-based shotgun metag-
enomic proﬁling, all were detected among the 16S proﬁles. Thirty-seven additional
families were seen only in the 16S data, including several families that are uniquely
enriched in the mouse (Turicibacteraceae and Odoribacteraceae [30]; Table S5). This
result underscores the utility of 16S-based taxonomic proﬁling in this study for detect-
ing and quantifying clades that are underrepresented in isolate genome catalogs.
Conversely, reference-based shotgun metagenomic proﬁles were advantageous in
providing increased taxonomic resolution in our data set. For example, unclassiﬁed
species of Streptococcus and Pasteurellaceae discovered through 16S sequencing were
revealed in the shotgun sequencing data to be Streptococcus parasanguinis and Hae-
mophilus parainﬂuenzae (Table S5). While we detected no major fungal community
members by shotgun sequencing, several viral species were detected (fungi and viruses
are notably invisible to 16S sequencing). Excluding trace viruses (i.e., present in one
sample at a relative abundance of 0.01%), the commonly occurring viruses were
mouse mammary tumor virus and murine osteosarcoma virus. Because these viruses
belong to the family Retroviridae, their detection may be due to endogenous copies in
the mouse genome that eluded host read depletion during metagenomic quality
control (e.g., due to absence or divergence from the mouse reference genome; see
Materials and Methods).
In addition to the NSTI-based evaluation of our predicted functional proﬁles, we
directly compared the predicted versus measured functional proﬁles for the subset of
samples subjected to both 16S and shotgun metagenomic sequencing. Predicted
versus measured gene family abundance (KEGG orthogroups [KOs]) were reasonably
concordant as measured by Spearman correlation, which ranged from 0.45 to 0.66
(Fig. S3). Notably, these values are in line with the expected agreement between
predicted and measured KO abundance proﬁles inferred from NSTI scores (see Fig. 3 in
reference 24), which lends further support to the accuracy of all predicted functional
proﬁles considered in this study.
While most shotgun metagenomes were saturated with respect to their measured
functional richness (Fig. S3), undersampling of low-abundance KOs could in principle
exaggerate the apparent disagreement between inferred and measured functional
proﬁles. However, the Spearman correlations cited above should be reasonably robust
to such events, meaning that any such exaggeration would be small. We suspect that
disagreements between our 16S-inferred and metagenomic functional proﬁles are
largely driven by the dependence of inferred proﬁles on a (complete) microbial
reference genome catalog, which may be missing ideal representatives for certain
mouse-associated species (consistent with the low but nonzero NSTI scores described
above).
DISCUSSION
Our study surveyed the effect of chronic ﬂuoride intake on oral and gut mouse
microbial communities. Speciﬁcally, using a combination of 16S rRNA gene and shot-
gun metagenomic sequencing, we proﬁled changes in the taxonomic and functional
composition of oral and gut communities following exposure to ﬂuoride treatment. Our
Fluoride Effects on Oral Microbiome
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data revealed that ﬂuoride exposures at levels commonly found in municipal water and
dental products induced statistically signiﬁcant changes in oral, but not stool, microbial
community structure and function. In the mouse models used here, microbes in the
oral community that are more typical of the gut microbiome (and likely derived from
coprophagy) were also selectively depleted by ﬂuoride treatment.
Due to its extremely widespread use in public health, it is important to understand
how ﬂuoride, even at low levels of exposure, might affect human-associated microbial
communities during or after chronic use. Fluoride use in humans was ﬁrst studied in the
1950s by assessing the toxicity of ﬂuoride on different host organ systems (31, 32) and
on cultures of select oral pathogens such as Streptococcus mutans (6–8). More recently,
two 16S sequencing studies of human populations have assessed the effect of ﬂuoride
on the dental plaque microbiome (13) (n  12) and orthodontic ﬁxed appliances (14)
(n  91). Both studies considered only the oral microbiome and, again, observed only
minor, low-effect size shifts in microbial composition longitudinally after ﬂuoride
exposure. Neither study included cross-sectional controls lacking ﬂuoride exposure, nor
were subjects at baseline free of chronic ﬂuoride exposures from routine dental
hygiene. To our knowledge, our work is thus the ﬁrst study to assess the independent
effects of ﬂuoride on the oral and gut microbial communities.
Previous in vitro studies have shown that ﬂuoride inhibits a wide variety of enzymes,
including phosphatases, pyrophosphatases, esterases, and catalases (33, 34). This inhi-
bition is typically due to interactions with cationic metal cofactors. Among the best-
characterized ﬂuoride-sensitive enzymes are those involved in glycolysis (e.g., enolase
[35]) and the citric acid cycle (e.g., succinate dehydrogenase [36]). However, the inputs
into both of these processes (glucose and pyruvate) can be alternatively metabolized
via the hexose monophosphate shunt or fermentation (37) if critical enzymes are
inhibited by ﬂuoride. Although enolase is the best-characterized ﬂuoride-sensitive
enzyme, it was not depleted in our functional data due to its universal carriage in
bacteria (38). Our data show, however, that in vivo ﬂuoride-associated modulation of in
vitro-demonstrated ﬂuoride-sensitive genes (such as succinate hydrogenase and
glyoxylate reductase [39]) is detected in metagenomic data. While 16S-based functional
predictions cannot associate speciﬁc gene polymorphisms with ﬂuoride sensitivity,
future studies aimed at speciﬁc microbial molecular products or physiology may
provide a higher-resolution look at speciﬁc genes and activities affected by ﬂuoride.
Our work, along with several previous, more-open-ended studies of human popu-
lations (13, 14), suggest that physiological ﬂuoride exposure levels have little effect on
the established gut microbiome and even on the overall composition of the oral
microbiome. An interesting open question, however, is the degree to which this
conclusion might differ in developing microbial communities such as the infant gut or
oral microbiota within the ﬁrst few years of life (40–42). While it is difﬁcult to model
early developing human microbial communities in mouse systems, we anticipate that
future work with carefully designed models, human populations, or directly investigat-
ing microbial physiology will continue to characterize the effects of this daily environ-
mental exposure on microbial community composition and function.
We have shown that exposures to ﬂuoride levels found in municipal water and
dental products altered oral, but not stool, microbial community structure and function
in mice. Speciﬁcally, genera containing acidogenic bacteria, such as Parabacteroides,
Bacteroides, and Bilophila, were depleted in the mouth, and ﬂuoride exposure was
associated with depletion of genes involved in central carbon metabolism and energy
harvest. In contrast, ﬂuoride treatment did not have a signiﬁcant effect on gut com-
munity composition or function, which is consistent with administered ﬂuoride not
reaching the gut to an appreciable extent. While the speciﬁc responding taxa in
humans and in mice are unlikely to be the same due to differences between human
systems and mouse models, the mechanisms of response and overall community
structural ecological changes are likely to be shared (43). We conclude that in our
model, exposure to ﬂuoride levels found in municipal water and dental products had
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selective effects on the composition of the oral microbial community but are unlikely
to have signiﬁcant effects on established gut microbial communities.
MATERIALS AND METHODS
Animal husbandry. Female BALB/c mice were weaned between postnatal days 18 to 21 and
randomized into experimental cages (four cages per treatment; seven mice per treatment) with an
adjustment period of handling the animals for 1 week, each cage containing two mice. Mice were fed
irradiated standard mouse chow (PicoLab Mouse diet 20 [catalog no. 5058; LabDiet, St. Louis, MO]). All
experiments were approved and conducted in accordance with Harvard Medical School Standing
Committee on Animals and National Institutes of Health guidelines.
Sample collection and processing. Stool samples were collected at weeks 0, 4, 8, and 12. Oral
samples were collected at weeks 0 and 12. Since the animals had to be euthanized to collect the oral
samples (to avoid mouse skin contamination), our week 0 oral samples were collected from a separate
set of mice (n 8) that were cohoused until randomization at week 0. The collected samples were stored
at80°C before processing. DNA was extracted using the MP Bio FastDNA Spin kit for soil (MP Bio, Santa
Ana, CA) according to the manufacturer’s instructions. For the 16S rRNA amplicon sequencing, the V4
region was ampliﬁed using the Earth Microbiome Project 16S sequencing protocol (44). In brief, genomic
DNA was subjected to 16S rRNA gene (16S) ampliﬁcations using primers designed incorporating the
Illumina adapters and a sample barcode sequence, allowing directional sequencing covering variable
region V4 (primers 515F [F stands for forward] [AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT ATG GTA
ATT GTG TGC CAG CMG CCG CGG TAA] and 806R [R stands for reverse] [GGACTACHVGGGTWTCTAAT]).
PCR mixtures contained 2 l of diluted template (5 to 50 ng/l of DNA), 10 l of HotMasterMix with the
HotMaster Taq DNA polymerase (5 Prime), and 0.5 l of primer mix (10 M of each primer). The cycling
conditions consisted of an initial denaturation of 94°C for 3 min, followed by 32 cycles of denaturation
at 94°C for 45 s, annealing at 50°C for 60 s, extension at 72°C for 5 min, and a ﬁnal extension at 72°C for
10 min. Amplicons were quantiﬁed using a Qubit 2.0 ﬂuorometer and Quant-iT PicoGreen double-
stranded DNA (dsDNA) assay kit (Invitrogen, Life Technologies). Integrity of DNA was tested by gel
electrophoresis (1% agarose gel). Quantiﬁed DNA was pooled in equimolar concentrations, size selected
(375 to 425 bp) on the Pippin Prep system (Sage Sciences, Beverly, MA) to reduce nonspeciﬁc ampliﬁ-
cation products from host DNA. Sequencing was performed on the Illumina MiSeq platform (version 2)
according to the manufacturer’s speciﬁcations with the addition of 15% PhiX and yielded paired-end
reads of 151 bp in length in each direction.
A subset of samples used for 16S sequencing was subjected to shotgun metagenomic sequencing.
This subset includes 6 oral samples (3 control samples and 3 samples from the high-ﬂuoride group at the
end of the study) and 11 stool samples (3 control samples and 2 or 3 samples from the high-ﬂuoride
group at the beginning and end of the study). Nextera libraries were prepared manually following the
manufacturer’s protocol (Nextera XT DNA Sample Prep kit; Illumina Inc., San Diego, CA). Brieﬂy, tagmen-
tation of samples was performed using 1 ng of template, and PCR ampliﬁcation was performed by a
Bio-Rad T100 thermocycler (Bio-Rad, Hercules, CA) following the manufacturer’s protocol. Agencourt
AMPure PCR puriﬁcation system (catalog no. A638801; Beckman Coulter, Brea, CA) was used to select for
300- to 500-bp fragments. The DNA libraries were validated with an Agilent 2100 bioanalyzer (Agilent
Technologies, Palo Alto, CA) and quantiﬁed using a Qubit2.0 ﬂuorometer (Thermo Fisher Scientiﬁc,
Waltham, MA). Equal volumes of normalized libraries were combined, diluted in hybridization buffer, and
heat denatured, according to Nextera XT protocol. Paired-end sequencing was performed using the
NextSeq Mid 150 cycle (2  75 bp).
Bioinformatic analysis of 16S and metagenomic shotgun sequencing. Overlapping 16S paired-
end reads were stitched together (approximately 97-bp overlap) and further processed in a data curation
pipeline implemented in QIIME 1.8.0 (QIIME stands for Quantitative Insights Into Microbial Ecology) as
pick_closed_reference_otus.py (44). In brief, this pipeline picks operational taxonomic units (OTUs) using
a reference-based method and then constructs an OTU table (see Table S4 in the supplemental material).
Taxonomy was assigned using the Greengenes (2013 version) predeﬁned taxonomy map of reference
sequence OTUs to taxonomy. A mean sequence depth of 134,046 reads per sample was obtained;
samples with fewer than 50,000 ﬁltered sequences were excluded from downstream analysis. Further
microbial community analyses such as beta diversity calculation and PERMANOVA between variables (i.e.,
treatment groups, time points, and cages) were performed using the weighted UniFrac distance measure
with QIIME 1.8.0 (44). Microbial functional modules were inferred from the 16S-based taxonomic proﬁles
using PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) (24),
and functional modules were reconstructed using HUMAnN (25).
Shotgun metagenomic sequences were ﬁrst adapter trimmed using cutadapt (45). Mouse reads were
removed using KneadData (http://huttenhower.sph.harvard.edu/kneaddata), which also trimmed low-
quality base pairs (Phred score  20) and ﬁltered short reads (trimmed length of 70% of original length).
Mouse reads were matched against the BALB/c genome dated February 2017 (http://www.sanger.ac.uk/
science/data/mouse-genomes-project). We performed taxonomic proﬁling using MetaPhlAn2 (29). Species
abundances (63 before ﬁltering) were passed through a ﬁlter requiring each species to have at least
0.01% abundance in at least 10% of all samples, resulting in 36 species for analysis (Table S5). Functional
proﬁles were generated using HUMAnN2 (25) (http://huttenhower.sph.harvard.edu/humann2). The Uni-
Ref90 database (46) was used for the translated search. UniRef90 abundances were collapsed to KEGG
Orthology (KO) groups (47) for comparison with PICRUSt output by mapping through UniProt-derived
annotations. KO rarefaction analysis (Fig. S3E) was carried out using the rarecurve function in R’s vegan
package (step set to 2,500) by providing per-sample KO and unmapped read counts as input.
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To test for statistically signiﬁcant microbial clades associated with ﬂuoride treatment and metadata,
we used the combination of LEfSe (17) for univariate and MaAsLin (Multivariate Associations by Linear
models) (21) for multivariate analyses. To ﬁnd taxa enriched in the oral and stool samples, we used LEfSe,
where classes are set as biogeographical locations (oral and stool). To identify taxa and functional
modules associated with ﬂuoride treatment in each oral sample and stool sample, we used MaAsLin to
build a multivariate linear model combining ﬁxed and random effects on each sample type. For the oral
samples, week 12 samples were used to identify taxa and functions that were perturbed by ﬂuoride
treatment group (control, low ﬂuoride, or high ﬂuoride). For the stool samples, ﬂuoride’s effects on taxa
and functions were ﬁrst tested on the combination of week 4, week 8, and week 12 samples, as these
were the time windows that would allow us to observe potential treatment effects. In this model, animal
age (week) and housing cage were included as covariates. We conducted a separate series of MaAsLin
in analyses stratifying the samples by week and including housing cage as the only covariate. Across
linear models, we applied Benjamini-Hochberg multiple testing correction with a target false-discovery
rate (FDR) of 0.2.
Determining ﬂuoride concentrations for use in mice. Mice in our study were treated with ﬂuoride
by inclusion in their drinking water (low- and high-ﬂuoride groups) and through additional gavage
(high-ﬂuoride group). The ﬂuoride concentrations in drinking water were designed to reﬂect human-
equivalent exposures. Speciﬁcally, we prepared water with 4 ppm ﬂuoride using sodium ﬂuoride
(solubility 99%; catalog no. S6776-100G, Sigma-Aldrich). This is the highest FDA-approved level of
ﬂuoride in municipal water in the United States. Mice in the low- and high-ﬂuoride groups drank from
this solution daily throughout the experiment. This is equivalent to a 0.02-g/day exposure, based on an
expected consumption of 5 ml of solution per day (48).
Mice in the high-ﬂuoride group received an additional dose of 2.25 g of ﬂuoride per day. This dose
was based on equivalent amounts of ﬂuoride that might be consumed by ingestion of ﬂuoridated
toothpastes in young children (1 to 3 years of age). Speciﬁcally, we assumed a 10-kg child consuming
one-quarter of 1 g of toothpaste per brushing session, twice per day, with a typical toothpaste ﬂuoride
concentration of 1,500 g per gram. This equates to 750 g per day for the 10-kg child, which is
equivalent to 2.25 g per day for a 30-g mouse (the expected average mass of our mice over the 12-week
time course). This additional ﬂuoride was given daily to mice in the high-ﬂuoride group by gavage in 10
l of deionized water.
Measuring ﬂuoride concentrations in the intestinal contents. We measured ﬂuoride ion concen-
trations in mouse stool samples using a ﬂuoride ion electrode probe (Cole-Parmer Instrumental Com-
pany, Vernon Hills, IL). We calibrated the probe using an initial 1,000 ppm ﬂuoride solution provided by
the manufacturer serially diluted to 0.001 ppm in deionized water. To analyze a given stool sample,
100 mg of dry stool was dissolved in 10 ml of deionized water. On the basis of the calibration curve, we
concluded that untreated mouse stool had a baseline ﬂuoride ion concentration of 0.064  0.032 g/ml
of dissolved stool (mean  standard deviation [SD], week 0 mice; Fig. S1). In comparison, stool ﬂuoride
concentrations after 12 weeks of low-ﬂuoride treatment were not appreciably larger than untreated
values at week 0 (0.036  0.013 g/ml of dissolved stool; P  0.997 by one-tailed t test). Fluoride
concentrations in stool samples from the high-ﬂuoride group were similarly unaffected (0.065 
0.023 g/ml of dissolved stool; P  0.820).
To conﬁrm that the probe was able to detect additional ﬂuoride in stool, we mixed untreated
dissolved stool samples with increasing concentrations of ﬂuoride. This produced a trend similar to the
standard calibration curve but ﬂattened below 0.15 g/ml of dissolved stool (consistent with the inability
to resolve concentrations of ﬂuoride below the baseline measurement for mouse stool). A follow-up
experiment using stool subjected to bead beating (to potentially release additional intracellular ﬂuoride)
produced a similar trend.
Accession number(s). Data needed to evaluate the conclusions in the paper are present in the paper
and supplemental material, and the sequences generated in this study are publicly available (NCBI
BioProject identiﬁcation [ID] or accession number PRJNA328099).
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